News

Filter

Current filters:

Reproductive

76 to 85 of 161 results

Changing the mood of Brazilian antidepressant market; fake Levitra

24-08-2011

The Vice President of Brazil’s Superior Court of Justice (STJ), Minister Felix Fischer, has restored…

BayerGenericsLevitraLexaproLundbeckNeurologicalPharmaceuticalRegulationReproductiveSouth America

Pfizer wins case to stop Teva selling generic Viagra in USA

16-08-2011

Global pharmaceutical behemoth Pfizer (NYSE: PFE) revealed yesterday that it has prevailed in its patent…

GenericsLegalNorth AmericaPatentsPfizerPharmaceuticalReproductiveTeva Pharmaceutical IndustriesViagra

Apricus Biosciences to file for topical ED drug Vitaros in Latin America

10-08-2011

San Diego, USA-based Apricus Biosciences (Nasdaq: APRI) says that it will file for market authorization…

AlprostadilApricus BiosciencePharmaceuticalRegulationReproductiveSouth AmericaVitaros

Teva gains EU approval for oral contraceptive Zoely

04-08-2011

There was good news for the world’s largest generics drugmaker Teva Pharmaceutical Industries (Nasdaq:…

EuropeGenericsPharmaceuticalRegulationReproductiveTeva Pharmaceutical IndustriesTheramexZoely

Watson debuts generic Seasonique in USA

28-07-2011

US generics major Watson Pharmaceuticals (NYSE: WPI) announced that its subsidiary, Watson Laboratories…

AmethiaDuramed PharmaceuticalsGenericsMarkets & MarketingNorth AmericaReproductiveSeasoniqueTeva Pharmaceutical IndustriesWatson Pharmaceuticals

Pfizer gains six months patent life for Lipitor on pediatric data; Bayer Yasmin patent scotched

11-07-2011

US drugs behemoth Pfizer (NYSE: PFE) could extend the European patent term for its al-time blockbuster…

BayerCardio-vascularEuropeGenericsLipitorPatentsPfizerPharmaceuticalReproductiveYasmin

US NDA filings for Vivus’ ED drug avanafil and Corcept’s Corlux for Cushing’s

01-07-2011

California, USA-based Vivus (Nasdaq: VVUS) has submitted a New Drug Application has to the Food and Drug…

avanafilCorluxNorth AmericaPharmaceuticalRare diseasesRegulationReproductiveVivus

Chiesi, Eli Lilly and Bayer named for breaches of the ABPI Code of Practice

31-05-2011

The UK subsidiaries of Italy’s Chiesi, US drug major Eli Lilly (NYSE: LLY) and Germany’s Bayer…

BayerChiesi FarmaceuticiEli LillyEuropeLevitraNeurologicalPharmaceuticalRegulationReproductiveYasmin

76 to 85 of 161 results

COMPANY SPOTLIGHT

Menarini

Back to top